Related references
Note: Only part of the references are listed.Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 1
Carl D. Regillo et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs
R. Bianco et al.
BRITISH JOURNAL OF CANCER (2008)
Vascular endothelial growth factor protein levels and gene expression in peripheral monocytes after stenting: a randomized comparative study of sirolimus: eluting and bare metal stents
George E. Kochiadakis et al.
EUROPEAN HEART JOURNAL (2008)
Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy
Olcay Tatar et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2007)
Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration
S. Aisenbrey et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2007)
Regulation of VEGF mRNA expression and protein secretion by TGF-β2 in human retinal pigment epithelial cells
Zong-Mei Bian et al.
EXPERIMENTAL EYE RESEARCH (2007)
Inhibition of TNF-α reduces laser-induced choroidal neovascularization
Xuan Shi et al.
EXPERIMENTAL EYE RESEARCH (2006)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits
Weiyun Shi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Regulating angiogenesis at the level of PtdIns-4,5-P2
Eunok Im et al.
EMBO JOURNAL (2006)
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
Qi-Wen Fan et al.
CANCER CELL (2006)
Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration
Richard F. Spaide et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
RL Avery et al.
OPHTHALMOLOGY (2006)
Countervailing effects of rapamycin (sirolimus) on nuclear factor-kappa B activities in neointimal and medial smooth muscle cells
Wolfgang Dichtl et al.
ATHEROSCLEROSIS (2006)
Endothelial progenitor cell sprouting in spheroid cultures is resistant to inhibition by osteoblasts: A model for bone replacement grafts
A Stahl et al.
FEBS LETTERS (2005)
Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition
SY Sun et al.
CANCER RESEARCH (2005)
Expression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degeneration
R Hera et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium
G Martin et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2004)
The TOR pathway: A target for cancer therapy
MA Bjornsti et al.
NATURE REVIEWS CANCER (2004)
Insulin-like growth factor-I and its receptor in neovascular age-related macular degeneration
AC Lambooij et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Cultivation of retinal pigment epithelial cells from human choroidal neovascular membranes in age related macular degeneration
G Schlunck et al.
EXPERIMENTAL EYE RESEARCH (2002)
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
M Guba et al.
NATURE MEDICINE (2002)
Two distinct signalling pathways are involved in FGF2-stimulated proliferation of choriocapillary endothelial cells: A comparative study with VEGF
A Zubilewicz et al.
ONCOGENE (2001)
Share Paper
